1. Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol 2017; 31: 205-12.
2.
Branisteanu DE, Cojocaru C, Diaconu R, et al. Update on the etiopathogenesis of psoriasis (Review). Exp Ther Med 2022; 23: 201.
3.
Armstrong AW, Armstrong EJ, Fuller EN, et al. Smoking and pathogenesis of psoriasis: a review of oxidative, inflammatory and genetic mechanisms. Br J Dermatol 2011; 165: 1162-8.
4.
Jin Y, Yang S, Zhang F, et al. Combined effects of HLA-Cw6 and cigarette smoking in psoriasis vulgaris: a hospital-based case-control study in China. J Eur Acad Dermatol Venereol 2009; 23: 132-7.
5.
Baba N, Rubio M, Kenins L, et al. The aryl hydrocarbon receptor (AhR) ligand VAF347 selectively acts on monocytes and naïve CD4+ Th cells to promote the development of IL-22-secreting Th cells. Hum Immunol 2012; 73: 795-800.
6.
Zhou H, Wu R, Kong Y, et al. Impact of smoking on psoriasis risk and treatment efficacy: a meta-analysis. J Intern Med Res 2020; 48: 0300060520964024.
7.
Fortes C, Mastroeni S, Leffondré K, et al. Relationship between smoking and the clinical severity of psoriasis. Arch Dermatol 2005; 141: 1580-4.
8.
Richer V, Roubille C, Fleming P, et al. Psoriasis and smoking: a systematic literature review and meta-analysis with qualitative analysis of effect of smoking on psoriasis severity. J Cutan Med Surg 2016; 20: 221-7.
9.
Herron MD, Hinckley M, Hoffman MS, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005; 141: 1527-34.
10.
Wei L, Chen S, Qiang Y, et al. Tobacco smoking was positively associated with metabolic syndrome among patients with psoriasis in Shanghai: a cross-sectional study. Tob Induc Dis 2022; 20: 05.
11.
Owczarczyk-Saczonek AB, Nowicki R. The association between smoking and the prevalence of metabolic syndrome and its components in patients with psoriasis aged 30 to 49 years. Adv Dermatol Allergol 2015; 32: 331-6.
12.
Boehncke WH, Boehncke S, Tobin AM, Kirby B. The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol 2011; 20: 303-7.
13.
Yu XL, Wu C, Jin HZ. Psoriasis, cardiovascular disease, and adipokines. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2018; 40: 556-62.
14.
Masson W, Lobo M, Molinero G. Psoriasis and cardiovascular risk: a comprehensive review. Adv Ther 2020; 37: 2017-33.
15.
Todberg T, Egeberg A, Zachariae C, et al. Patients with psoriasis have a dysbiotic taxonomic and functional gut microbiota. Br J Dermatol 2022; 187: 89-98.
16.
Buhaș MC, Gavrilaș LI, Candrea R, et al. Gut microbiota in psoriasis. Nutrients 2022; 14: 2970.
17.
Todberg T, Kaiser H, Zachariae C, et al. Characterization of the oral and gut microbiota in patients with psoriatic diseases: a systematic review. Acta Derm Venereol 2021; 101: adv00512.
18.
Capurso G, Lahner E. The interaction between smoking, alcohol and the gut microbiome. Best Pract Res Clin Gastroenterol 2017; 31: 579-88.
19.
Pezzolo E, Naldi L. The relationship between smoking, psoriasis and psoriatic arthritis. Exp Rev Clin Immunol 2019; 15: 41-8.
20.
Gazel U, Ayan G, Solmaz D, et al. The impact of smoking on prevalence of psoriasis and psoriatic arthritis. Rheumatology (Oxford) 2020; 59: 2695-710..
21.
Nguyen UDT, Zhang Y, Lu N, et al. Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: a population-based study. Ann Rheum Dis 2018; 77: 119-23.
22.
Vaengebjerg S, Skov L, Egeberg A, Loft ND. Prevalence, incidence, and risk of cancer in patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysis. JAMA Dermatol 2020; 156: 421-9.
23.
Trafford AM, Parisi R, Kontopantelis E, et al. Association of psoriasis with the risk of developing or dying of cancer: a systematic review and meta-analysis. JAMA Dermatol 2019; 155: 1390-403.
24.
Owczarczyk-Saczonek A, Kasprowicz-Furmańczyk M, Krajewska-Włodarczyk M, Griffiths CEM. Does the lifestyle of patients with psoriasis affect their illness? Post Hig Med Doœw 2021; 75: 643-54.
25.
Serwin AB, Sokołowska M, Chodynicka B. Tumor necrosis factor-alpha-converting enzyme as a potential mediator of the influence of smoking on the response to treatment with narrow band ultraviolet B in psoriasis patients. Photodermatol Photoimmunol Photomed 2010; 6: 36-40.
26.
Audrain-McGovern J, Leventhal AM, Strong DR. The role of depression in the uptake and maintenance of cigarette smoking. Int Rev Neurobiol 2015; 124: 209-43.
27.
Semba J, Wakuta M, Maeda J, Suhara T. Nicotine withdrawal induces subsensitivity of hypothalamic-pituitary-adrenal axis to stress in rats: implications for precipitation of depression during smoking cessation. Psychoneuroendocrinology 2004; 29: 215-26.
28.
Paluska SA, Schwenk TL. Physical activity and mental health: current concepts. Sports Med 2000; 29: 167-80.
29.
Goyal M, Singh S, Sibinga EMS, et al. Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Intern Med 2014; 174: 357-68.
30.
Cacciapuoti S, Luciano MA, Megna M, et al. The role of thermal water in chronic skin diseases management: a review of the literature. J Clin Med 2020; 9: 3047.
31.
Armour M, Smith CA, Wang LQ, et al. Acupuncture for depression: a systematic review and meta-analysis. J Clin Med 2019; 8: 1140.
32.
Du J, Tao J, Xu M, et al. The effects of acupuncture for patients with psoriasis: study protocol for a randomized controlled trial. Medicine (Baltimore) 2021; 100: e26042.
33.
Ji YZ, Liu SR. Koebner phenomenon leading to the formation of new psoriatic lesions: evidences and mechanisms. Biosci Rep 2019; 39: BSR20193266.
34.
Tan C, Jiang J, Deng X, et al. Effect of cognitive behavioral therapy on anxiety and depression in patients with psoriasis: a protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021; 100: e27720.
